Introduction {#s1}
============

Homologous recombination (HR) is a highly conserved mechanism for the repair of DNA double-strand breaks and stalled replication forks. HR defects are associated with many hereditary and sporadic cancers ([@bib8]), thus underlining the essential nature of this process. HR involves the interaction of the 3\'-end of single stranded DNA (ssDNA) with a homologous double-stranded DNA (dsDNA) molecule that is used as a template for DNA synthesis. In eukaryotes, the recombinase RAD51 forms a nucleoprotein filament on ssDNA that performs synapsis and strand invasion of the homologous duplex DNA to form a stable D-loop. The resolution of the joint molecules completes repair (reviewed in [@bib36]; [@bib44]).

RAD51 filament formation on ssDNA coated by the ssDNA-binding protein RPA requires additional factors, such as the mammalian mediator BRCA2 ([@bib19]; [@bib26]; [@bib39]; [@bib46]; [@bib53]) or the yeast protein Rad52 (reviewed in [@bib44]). In yeast, Rad52 is the most important mediator of Rad51 filament formation and it was proposed that this function involves its interaction with both RPA and Rad51. A domain essential for interaction with RPA was identified ([@bib34]) and two motifs, FVTA at position 316--319 and YEKF at position 376--379, are each essential for interaction with Rad51 ([@bib23]; [@bib20]) ([Figure 1a](#fig1){ref-type="fig"}). In mammalian cells, RAD51 filament formation is mainly driven by BRCA2 and the role of RAD52 is still enigmatic ([@bib28]). RAD52 is required for the viability of BRCA2-deficient cells ([@bib14]), underlining the importance of its function. Recent studies revealed a role for RAD52 pairing activity in promoting DNA synthesis following replication stress ([@bib5]; [@bib41]). However, RAD52 interaction with RPA and RAD51 ([@bib33]; [@bib40]) suggests that RAD52 has a role in RAD51 filament regulation also in mammalian cells.

![Mutations in the Rad51-binding domain of Rad52 suppress MMS and γ-ray sensitivity of Srs2-deficient cells.\
(**A**) Primary structure of Rad52. The conserved N-terminus as well as the RPA and the Rad51 binding domains (BD) are shown. (**B**) The mutations selected from random and directed mutagenesis are indicated on the alignment of the region 350-389aa of *S. cerevisiae* Rad52 with that of Rad52 orthologs in 12 fungal species. The amino acid colors refer to the chemical character of the residues. The *rad52-P381S* and *rad52-Y376A* mutations are underlined. (**C**) Serial 10-fold dilutions of haploid strains with the indicated genotypes were spotted onto rich media (YPD) containing different MMS concentrations. The data presented are a selection from those in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. (**D,E,F**) Survival curves of haploid cells exposed to γ-ray. *rad52-YEKF*∆ cells were from two different genetic backgrounds: FF18733 (FF) and W303. Data are presented as the mean ± SEM of at least three independent experiments.\
10.7554/eLife.32744.005Figure 1---source data 1.Survival (%) of haploid cells exposed to γ-ray for [Figure 1D,E and F](#fig1){ref-type="fig"}.](elife-32744-fig1){#fig1}

It was shown in yeast that the DNA translocase Srs2 is required to avoid the accumulation of toxic Rad51 filaments. Specifically, HR is accountable for the sensitivity of Srs2-deficient cells to DNA damage. As Srs2 can dismantle Rad51 filaments in vitro, the accumulation of toxic Rad51 filaments in Srs2-deficient cells is probably responsible for this sensitivity ([@bib6]; [@bib13]; [@bib24]; [@bib49]). The unproductive association of Rad51 with ssDNA could interfere with the normal progression of DNA replication forks or DNA repair ([@bib1]; [@bib22]; [@bib47]). However, this control of toxic filaments suggests that functional Rad51 filaments are protected from Srs2 activity. The Rad55/57 and SHU complex, which contains Rad51 paralog proteins, was shown to provide such protection ([@bib4]; [@bib15]; [@bib29]).

In several organisms, RAD51 paralogs also stabilize RAD51 filaments by inhibiting RAD51 dissociation from ssDNA ([@bib45]; [@bib9]; [@bib29]), thus ensuring the success of homology search. Rad52 might also share this role as shown by its association with Rad51 filaments after their formation ([@bib13]). In this study, we proposed that this association is responsible for the toxicity of Rad51 filaments in Srs2-deficient cells because Rad52 mutations that do not affect Rad51 filament formation suppress the sensitivity of Srs2-deficient cells to DNA-damaging agents. We also found that *SIZ2* overexpression promotes massive Rad52 sumoylation and leads to the suppression of Rad51 filament toxicity in Srs2-deficient cells. Therefore, we hypothesized that Rad52 sumoylation could trigger Rad52 dissociation from Rad51 filaments ([@bib13]).

We sought to better understand the role of Rad52 in the formation of toxic Rad51 filaments. To this aim, we used a random mutagenesis approach to select new *RAD52* gene mutations that suppress the sensitivity of Srs2-deficient cells to DNA damage. We found mutations that restrict the interaction between Rad52 and Rad51, showing that this interaction is responsible for Rad51 filament toxicity in Srs2-deficient cells. Unexpectedly, our genetic and molecular analyses show that the interaction between Rad52 and Rad51 is not absolutely required for Rad51 filament assembly. Additionally, we found that in Srs2-proficient cells, Rad52 is required to protect Rad51 filaments from disruption by Srs2. Altogether, our results bring a different view on the regulation of Rad51 filaments by Rad52 and Srs2. We propose a unified model to explain the crucial roles of Rad52 and Srs2. The newly identified Rad52 role could be extended to other eukaryotes and to other mediator proteins.

Results {#s2}
=======

Identification of *rad52* mutants that suppress Rad51 filament toxicity in Srs2-deficient cells {#s2-1}
-----------------------------------------------------------------------------------------------

To better understand the role of Rad52 in Rad51 filament toxicity in Srs2-deficient cells, we searched for *rad52* mutants that upon DNA damage, suppress the lethality induced by Rad51 toxic filaments generated in the absence of Srs2. To this aim, we screened a *RAD52* randomly mutated plasmid library to identify mutants that suppress the sensitivity of cells lacking *RAD52* and *SRS2* (*rad52*∆ *srs2*∆) to high dose of methyl methanesulfonate (MMS, 0.015%). We used cells lacking both *SRS2* and *RAD52* to find *RAD52* mutations that complement the essential functions of this gene in Rad51 filament formation. To confirm that the suppression phenotype of the selected mutants was only caused by the mutation carried by the selected plasmids and not by background mutations, we isolated each plasmid from these strains and used them to transform again *rad52*∆ *srs2*∆ cells. Evaluation of resistance to MMS by spot assay ([Figure 1---figure supplement 1a](#fig1s1){ref-type="fig"}) showed that each isolated plasmid significantly restored MMS resistance in *rad52*∆ *srs2*∆ cells. The list of selected mutations is in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Particularly, we found mutations in three consecutive residues, F~379~ A~380~ P~381~ ([Figure 1b](#fig1){ref-type="fig"}), that define the FAP domain. F~379~ belongs to the YEKF motif at position 376--379 ([Figure 1a](#fig1){ref-type="fig"}), the deletion of which strongly impairs Rad52 binding to Rad51 ([@bib23]). We chose for the subsequent analyses a representative FAP mutant (*rad52-P381S*) because it strongly reduced sensitivity to MMS in Srs2-deficient cells ([Figure 1c](#fig1){ref-type="fig"}). The strong suppression was confirmed by the finding that the survival rate of *rad52-P381S srs2*∆ cells exposed to γ-rays was comparable to that of wild type (WT) cells ([Figure 1d](#fig1){ref-type="fig"}).

The Rad52 YEKF domain of interaction with Rad51 is involved in Rad51 filament toxicity, but is dispensable for HR {#s2-2}
-----------------------------------------------------------------------------------------------------------------

The fact that F~379~ belongs to the YEKF domain involved in Rad52 binding to Rad51 ([@bib23]) suggests that the interaction between the two proteins is effectively involved in Rad51 filaments toxicity. To test further this correlation, we measured the MMS and γ-ray sensitivity of Srs2-defective cells carrying a mutation in one of the six well-conserved amino acids identified by sequence alignment in or around the YEKFAP domain of 12 Rad52 orthologs in fungi ([Figure 1b](#fig1){ref-type="fig"}). First, we assessed the capacity of each mutation to suppress MMS sensitivity of *rad52*∆ *srs2*∆ cells by spot assay. We found that *rad52-Y376A* fully suppressed the MMS and also γ-ray sensitivity of Srs2-deficient cells ([Figure 1c,d](#fig1){ref-type="fig"}), whereas the effect of the *rad52-K378A* and *rad52-G383A* mutations was less strong ([Figure 1---figure supplement 1b,d](#fig1s1){ref-type="fig"}). This mutational analysis suggests a link between the Rad51-binding domain in Rad52 and the potential toxicity of Rad51 filaments. Accordingly, crossing *rad52-Y376A srs2*Δ haploid cells with DNA repair or replication haploid mutants, such as *rad50*∆, *rad54*∆, *rrm3*∆, *mrc1*∆, *ctf18*∆ and *sgs1*∆, also suppressed the synthetic sickness or lethality observed in the absence of Srs2 ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) and attributed to the accumulation of toxic Rad51 filaments ([@bib13]). The *rad52-P381S* allele could not suppress lethality, indicating that its effect on Rad51 filaments toxicity is less important than that of *rad52-Y376A*.

To assess the effect of Rad51-binding domain mutations on Rad52 function, we transformed Rad52-deficient cells (but proficient for Srs2) with plasmids harboring *RAD52* mutations. Most of them restored almost completely resistance to genotoxic agents in *rad52*∆ cells ([Figure 1---figure supplement 1c,e](#fig1s1){ref-type="fig"}). However, the *rad52-Y376A* mutant did not fully rescue the phenotype of *rad52*∆ cells ([Figure 1c](#fig1){ref-type="fig"}), as indicated also by the six-fold reduction in survival at 200Gy compared with WT ([Figure 1e](#fig1){ref-type="fig"}). Nevertheless, the survival rate of *rad52-Y376A* cells was higher than that of Rad52-deficient cells ([Figure 1c](#fig1){ref-type="fig"}). Similarly, we found that the survival rate of cells in which the *YEKF* motif was deleted was much higher than that of Rad52-deficient cells, independently of the strain background ([Figure 1f](#fig1){ref-type="fig"}). The relatively lower γ-ray and MMS sensitivity of cells bearing mutations around the YEKFAP-binding domain compared with Rad52-deficient cells suggests that this interaction is largely dispensable for the formation of functional Rad51 filaments. This hypothesis was strengthened by the finding that inactivation of the *SRS2* gene fully suppressed the γ-ray and MMS sensitivity of *rad52-Y376A* cells ([Figure 1c,e](#fig1){ref-type="fig"}). Therefore, the sensitivity of *rad52-Y376A* cells to genotoxic agents is not related to a reduced Rad52 mediator activity, but results from Srs2 activity. This suggests a completely new view on Rad51 filament homeostasis because Rad52 appears to be essential for Rad51 filament assembly only through its interaction with RPA, whereas its interaction with Rad51 is dispensable. The Rad51-Rad52 interaction seems to be mostly required for the protection of Rad51 filaments from disruption by the translocase Srs2, and for the toxicity of Rad51 filaments in Srs2-deficient cells.

The *rad52-Y376A* and *rad52-P381S* mutations impact the interaction between Rad52 and Rad51 {#s2-3}
--------------------------------------------------------------------------------------------

To further address the relationship between the potential toxicity of Rad51 filaments and the interaction of Rad51 with Rad52, we tested the effect of Rad52 mutations around the YEKFAP domain on the capacity of FLAG-tagged Rad52 to co-immunoprecipitate with Rad51 ([Figure 2a](#fig2){ref-type="fig"}). First, we confirmed that the interaction between Rad52 and Rad51 cannot be detected in cells that carry a deletion in the Rad52-YEKF motif ([@bib23]). We obtained the same result in *rad52-Y376A* cells, whereas in *rad52-P381S*, *rad52-K378A* and *rad52-G383A* cells the interaction was detectable but significantly reduced compared with WT. Conversely, in *rad52-S374A* cells in which the growth defect of *srs2*∆ cells on MMS-containing medium is not suppressed ([Figure 1---figure supplement 1b](#fig1s1){ref-type="fig"}), the Rad52-Rad51 interaction was only slightly affected. Altogether, these results indicate that there is a correlation between the ability of the *rad52* mutants to interact with Rad51 and their capacity to suppress *srs2*∆ cells phenotypes. This suggests a correlation between the Rad52-Rad51 interaction and the potential toxicity of Rad51 filaments.

![Measurement of Rad52-Rad51 interaction in cells that express various *Rad52-FLAG* mutants.\
(**A**) Rad51 immunoprecipitation from cells that express different Rad52-FLAG mutants. The anti-Dps1 antibody was used as loading control. The signals corresponding to immunoprecipitated Rad52 mutants (Blot: αFLAG) were quantified relatively to the signal for WT Rad52, corrected to the quantity of Rad52 in each extracts (Extracts: αFLAG) and to the Dps1 signal (αDps1). Data are presented as the mean ± SEM (n = 3). Fisher's exact test, n.s. p\>0.05, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. (**B**) Purification of recombinant Rad52-FLAG, Rad52-P381S-FLAG and Rad52-Y376A-FLAG. (**C**) Pull-down experiments using Rad52-FLAG WT or Y376A fusion protein in the presence of different salt concentrations.\
10.7554/eLife.32744.007Figure 2---source data 1.Relative IP (%) and Two-tailed p values, unpaired T test for [Figure 2A](#fig2){ref-type="fig"}.](elife-32744-fig2){#fig2}

To verify that the mutations in the binding domain have a direct effect on the interaction between Rad52 and Rad51, we measured in vitro the consequences of the mutation that affected the most the interaction (i.e. *rad52-Y376A*). Pull-down experiments with purified Rad52 and Rad52-Y376A FLAG-tagged proteins ([Figure 2b](#fig2){ref-type="fig"}) showed that this mutation impaired very strongly the interaction with Rad51 ([Figure 2c](#fig2){ref-type="fig"}). By performing pull-down assays in the presence of low-salt concentrations (40 mM instead of 140 mM NaCl), we observed a residual interaction between Rad51 and Rad52-Y376A-FLAG. We cannot fully exclude that this residual interaction provides mediator activity to Rad52-Y376A-FLAG.

Rad52 interaction with Rad51 is dispensable for gene conversion {#s2-4}
---------------------------------------------------------------

To strengthen our conclusion that the interaction between Rad52 and Rad51 is not required for Rad51 filament formation, we measured the rate of γ-ray-induced HR between *arg4-RV* and *arg4-Bg* heteroalleles in diploid cells ([Figure 3a](#fig3){ref-type="fig"}). We decided to focus on the *rad52-P381S* and *rad52-Y376A* mutations because they are representative of a partial and a strong loss of interaction, respectively. Like in haploid cells, *rad52-P381S* homozygous diploids were only slightly more sensitive to γ-ray irradiation than WT cells, whereas *rad52-Y376A* showed much higher sensitivity ([Figure 3b](#fig3){ref-type="fig"}). However, HR frequencies were comparable in mutant and WT cells, indicating that the impaired interaction between Rad52 and Rad51 does not prevent the recovery of ARG^+^ recombinants in the surviving cells.

![Effect of the *rad52-P381S* and *rad52-Y376A* alleles on HR.\
(**A**) Recombination system allowing the formation of a WT *ARG4* allele by gene conversion of the *arg4-RV* or *arg4-Bg* heteroalleles in diploid cells. (**B, C**) Survival curves (black) and heteroallelic HR frequencies (red) for the indicated homozygous diploid cells exposed to γ-rays. Data are presented as the mean ± SEM of at least three independent experiments. (**D**) HO-induced gene conversion between *MAT* ectopic copies. Cell viability after DSB formation is shown as the mean ± SEM of at least three independent experiments. Fisher's exact test, n.s. p\>0.05, \*p\<0.05.\
10.7554/eLife.32744.009Figure 3---source data 1.Source data for [Figure 3B,C and D](#fig3){ref-type="fig"}.](elife-32744-fig3){#fig3}

Remarkably, the strong hyper-recombination phenotype associated with acute sensitivity to γ-ray of Srs2-deficient diploid cells was partially suppressed by the *rad52-P381S* mutation and strongly suppressed by *rad52-Y376A*. Indeed, *rad52-Y376A srs2*∆ homozygous diploid cells were 1000 times more resistant than *srs2*∆ cells to exposure to 400 Gy and the HR frequency was 800-fold reduced ([Figure 3c](#fig3){ref-type="fig"}). This indicates that the Rad52-Rad51 interaction is responsible for the high lethality and strong hyper-recombination phenotype observed in Srs2-deficient cells.

We also measured the effect of both *RAD52* mutants on DSB repair. To this aim, we used a genetic system that allows the repair of a HO-induced DSB at the *MAT* locus of haploid cells (chromosome III) by gene conversion using another *MAT* copy located on chromosome V ([Figure 3d](#fig3){ref-type="fig"}) ([@bib18]). We observed that the *rad52-P381S* and *rad52-Y376A* mutations affected cell survival only marginally, again indicating that the Rad52-Rad51 interaction is not essential for DSB repair by HR, and by extension for Rad51 filament formation. As observed before ([@bib18]), DSB formation strongly reduced survival of Srs2-deficient cells. These authors showed that cell lethality following DSB formation was associated with increased crossing-over rate. This was interpreted as a failure to resolve HR events through the synthesis-dependent strand annealing (SDSA) pathway (gene conversion without crossing-over) in the absence of Srs2 activity. The *RAD52* mutants had only a marginal effect on survival of Srs2-deficient cells, indicating that they cannot rescue the SDSA defect.

Rad52 interaction with Rad51 is dispensable for Rad51 filament formation at a HO-induced DSB, but is essential for preventing Rad51 filament disassembly by Srs2 {#s2-5}
----------------------------------------------------------------------------------------------------------------------------------------------------------------

Our data suggest that the Rad52-Rad51 interaction is not essential for Rad51 filament formation. To test this hypothesis, we measured the recruitment of proteins involved in Rad51 filament formation by chromatin immunoprecipitation experiments (ChIP) in haploid cells that express WT or mutant Rad52-FLAG. We used a system designed by [@bib48]) where a HO-induced DSB can be repaired by single strand annealing (SSA) between direct repeats located 25 kb apart (SSA assay) ([Figure 4a](#fig4){ref-type="fig"}). This assay involves the formation of long 3\'-end ssDNA tails generated from the DSB, thus ensuring the sensitive detection of RPA, Rad52-FLAG and Rad51 recruitment to the DSB site. Quantitative PCR assays using primer sets that amplify DNA sequences at 0.6 or 7.6 kb upstream of the DSB site at different time points after DSB induction ([Figure 4b](#fig4){ref-type="fig"}) showed an increase of the relative enrichment of RPA, Rad52-FLAG and Rad51 at the site of DSB formation compared with the uncut *ARG5,6* locus. RPA, Rad52-FLAG and Rad51 loading peaked after 4 hr and was lower at 7.6 kb (green) than at 0.6 kb (red) ([Figure 4b](#fig4){ref-type="fig"}), as described previously ([@bib13]). This is indicative of RPA, Rad52-FLAG and Rad51 loading after ssDNA formation. As previously described, Rad51 enrichment increased in *srs2*∆ cells ([@bib13]), particularly at 7.6 kb, showing that Srs2 displaces Rad51 much more efficiently at distant sites.

![ChIP analysis of Rad51 filament formation at a DSB created by the HO endonuclease.\
(**A**) Schematic of the HO-induced SSA repair system. (**B**) ChIP was used to assess RPA, Rad52 and Rad51 relative enrichment at 0.6 or 7.6 kb from the DSB site and at the uncut *ARG5,6* locus at the indicated time points (hours) after HO induction. The median value (n ≥ 2) is shown and error bars represent the upper and lower values measured. Fisher's exact test, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. Statistical analysis was performed 4 hr after HO-induction; only significant differences are shown. (**C**) Cell survival after HO-induced DSB formation. Cell viability after DSB formation is shown as the mean ± SEM of at least three independent experiments. Fisher's exact test, \*\*\*p\<0.001.\
10.7554/eLife.32744.013Figure 4---source data 1.Source data for [Figure 4A](#fig4){ref-type="fig"}.](elife-32744-fig4){#fig4}

Compared with WT cells, Rad51 loading did not significantly change in cells that express Rad52-P381S-FLAG ([Figure 4---figure supplement 1b](#fig4s1){ref-type="fig"}), whereas it was significantly reduced by 2.2-fold in *rad52-Y376A-FLAG* cells ([Figure 4b](#fig4){ref-type="fig"}). Conversely, RPA loading was 1.5-fold increased. This could be interpreted as a deficiency of Rad52 mediator activity. However, in *rad52-Y376A-FLAG srs2*∆ cells, Rad51 loading was 3.6-fold higher than in *rad52-Y376*A*-FLAG* cells and similar to that in *srs2*∆ cells ([Figure 4b](#fig4){ref-type="fig"}). Therefore, the reduction in Rad51 loading observed in *rad52-Y376A-FLAG* cells fully depended on Srs2 activity. These results confirmed that the Rad52-Rad51 interaction is not required to recruit Rad51 at the DSB site, and that the association between Rad52 and Rad51 is crucial for preventing Rad51 filament disassembly by Srs2.

The Rad52-Rad51 interaction is required for the toxicity of Rad51 filaments forming around a DSB in Srs2-deficient cells {#s2-6}
------------------------------------------------------------------------------------------------------------------------

Cell survival after DSB formation in the SSA assay depends on *RAD52* [@bib48]), probably through its ssDNA pairing activity that catalyzes the annealing between homologous ssDNA. However, the *rad52-P381S* and *rad52-Y376A* mutations did not affect cell survival ([Figure 4c](#fig4){ref-type="fig"}). This suggested that these Rad52 mutations do not alter Rad52 pairing activity. Srs2 also is essential for cell survival, a result confirmed here ([Figure 4c](#fig4){ref-type="fig"}), but not Rad51 ([@bib48]). It has been proposed that Srs2 is required to remove Rad51 that accumulates on long 3\'-ssDNA generated from DSB processing ([@bib47]) and to avoid the formation of branched toxic joint molecules upon ssDNA invasion at ectopic positions ([@bib12]). On the other hand, viability was partially improved in *rad52-P381S srs2*∆ cells and fully restored in *rad52-Y376A srs2*∆ cells ([Figure 4c](#fig4){ref-type="fig"}). As our ChIP experiments showed that Rad51 is recruited normally in these double mutants, we think that this suppressor phenotype is not the consequence of impaired Rad51 filament formation. We propose instead that losing the interaction between Rad52 and Rad51 leads to less stable Rad51 filaments that are less toxic on long 3'-ssDNA in the absence of Srs2 activity.

In vitro analysis of Rad52 activities when interaction with Rad51 is altered {#s2-7}
----------------------------------------------------------------------------

Altogether, our results suggested that the Rad52-Rad51 interaction is not essential for Rad51 filament formation, but makes Rad51 filaments toxic in Srs2-deficient cells. In Srs2-proficient cells, Rad52-Rad51 interaction could be essential to protect Rad51 filaments from Srs2 dismantling activity. To further test these hypotheses, we examined the effect of mutations that affect Rad52-Rad51 interaction on Rad52 biochemical properties in vitro. Using electrophoretic mobility shift assays, we found that the mutated proteins Rad52-P381S and Rad52-Y376A (FLAG-tagged) bound to ssDNA and dsDNA similarly to WT ([Figure 5---figure supplement 1a](#fig5s1){ref-type="fig"}). Moreover, they annealed complementary ssDNA strands as efficiently as WT and were subject to inhibition by RPA and Rad51 as well ([Figure 5---figure supplement 1b](#fig5s1){ref-type="fig"}; [@bib51]).

We then used electron microscopy (EM) to determine the effect of Rad52 mutations on Rad51 filament formation on 5 kb-long φX174 viral (+) ssDNA ([Figure 5a](#fig5){ref-type="fig"}). As described before (reviewed in [@bib36]), incubation of Rad51 with φX174 viral (+) ssDNA prior to RPA addition produced complete Rad51 filaments, on which Rad51 fully covered ssDNA. Conversely, addition of Rad51 to RPA-coated ssDNA mostly led to the production of partial Rad51 filaments. The concomitant addition of Rad52 and Rad51 to RPA-coated ssDNA allowed the formation of complete Rad51 filaments (100%), confirming that Rad52 overcomes RPA inhibitory effect. Addition of Rad52-P381S or Rad52-Y376A, instead of Rad52, to RPA-coated ssDNA led mostly to the formation of complete Rad51 filaments (85 and 73%, respectively). However, the significant increase in the amount of RPA filaments still present at the end of the reaction suggests a slight defect in the capacity of these Rad52 mutants to start the nucleation process that initiates Rad51 filament formation.

![Biochemical analysis of Rad52-P381S and Rad52-Y376A mutant proteins.\
All experiments were performed with FLAG-tagged Rad52 proteins. (**A**) EM analysis of Rad51 filament formation. A representative nucleofilament issued from each reaction is shown. Addition of Rad51 prior to RPA on circular φx174 ssDNA (Rad51 RPA) forms complete Rad51 filaments, whereas addition of RPA before Rad51 (RPA Rad51) results in partial Rad51 filaments. White arrows indicate the presence of RPA on ssDNA. Concomitant addition of Rad52 with Rad51 in this reaction (RPA Rad51 Rad52) leads to complete Rad51 filaments associated with Rad52 (white arrows). The percentage of each molecular species is plotted on the histogram (right panel), showing the weak effect of Rad52 mutants on Rad51 filament formation. Two independent experiments were performed with very similar results. The results of the individual biological replicates were pooled (300 molecules analyzed). (**B**) Number of Rad52, Rad52-P381S and Rad52-Y376A molecules associated with Rad51 filaments assembled at two NaCl concentrations (n = 40). The median value is represented by the horizontal bar. Fisher's exact test, \*\*\*p\<0.001. (**C**) Effect of Rad52 mutants on strand exchange. The standard reaction (Rad51 RPA) shows that complete Rad51 filaments efficiently catalyze the formation of nicked circular products. Pre-bound RPA inhibits this reaction (RPA Rad51); however, the inhibitory effect of pre-bound RPA is overcome by Rad52 (RPA Rad51 Rad52) and, to a lesser extent, by the Rad52 mutants tested. The percentage of nicked circular product calculated by quantification of the gels is shown. Data are presented as the mean ± SEM of at least three independent experiments. Fisher's exact test, n.s. p\>0.05, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. (**D**) EM analysis of Rad51 filament displacement by Srs2. Srs2 was added for 5 min at the end of the Rad51 filament formation reactions (Rad51 RPA Srs2 and RPA Rad51 Rad52 Srs2). The white arrow shows the appearance of RPA on Rad52-Y376A-assembled Rad51 filaments after Srs2 addition. The percentage of each molecular species is shown in the histogram. Two independent experiments were performed with very similar results. The results of the individual biological replicates were pooled (200 molecules analyzed). (**E**) Rad52 increases strand exchange efficiency in the presence of Srs2. Strand exchange reactions were performed as in (**C**) except that increasing concentrations of Srs2 were added with the linear dsDNA for 90 min. Data are shown as the mean ± SEM of at least three independent experiments. (**F**) Pull-down assay with an anti-FLAG antibody shows the interaction between Rad52 and Srs2.\
10.7554/eLife.32744.020Figure 5---source data 1.Source data for [Figure 5E](#fig5){ref-type="fig"}.](elife-32744-fig5){#fig5}

These results confirmed that despite their weak ability to interact with Rad51, the mutant proteins can bypass RPA and form Rad51 filaments with high efficiency. They also confirmed our previous observation ([@bib13]) that Rad52 remains associated with Rad51 filaments ([Figure 5a](#fig5){ref-type="fig"}). The two Rad52 mutant proteins also remained associated with Rad51 filaments, albeit to a lower extent compared with WT Rad52 ([Figure 5b](#fig5){ref-type="fig"}). This was surprising because the Rad52-Y376A variant harbors a mutation that largely impairs the interaction with Rad51 (our co-immunoprecipitation and pull-down experiments; [Figure 2a,c](#fig2){ref-type="fig"}). This difference could be explained by the low-salt concentration classically used for Rad51 filament formation in EM experiments (40 mM KCl). Indeed, Rad51 filament formation in the presence of 140 mM KCl led to a weaker association of WT and mutant Rad52 with Rad51 filaments, but Rad52-Y376A was still associated with Rad51 filaments.

Previous experiments showed that the in vitro φX174-based strand exchange reaction is significantly affected by *rad52-YEKF*∆ ([@bib23]). However, we found that Rad52-P381S and Rad52-Y376A did not strongly affect Rad51 filament formation on φX174 ssDNA and that they efficiently promoted HR in vivo. Therefore, we tested the two mutated proteins in the strand exchange experiment ([Figure 5c](#fig5){ref-type="fig"}). As previously described, RPA pre-bound to ssDNA reduced strand exchange by approximately fourfold compared to the standard reaction, where Rad51 is added prior to RPA. The concomitant addition of Rad52 and Rad51 released the inhibition by pre-bound RPA and led to a threefold increase in strand exchange. We found that Rad52-P381S can release the RPA inhibition as efficiently as the WT protein, whereas Rad52-Y376A is affected, confirming the results obtained with Rad52-YEKF∆. Although Rad51 filament formation mediated by the mutated Rad52 proteins was only slightly affected, strand exchange in vitro was strongly affected. This is in contrast with our observation in vivo, suggesting that other activities could compensate for the Rad52 mutations in vivo.

Finally, we tested whether Rad52-Rad51 interaction stabilizes Rad51 filaments. This effect could explain how Rad52 triggers Rad51 filament toxicity in Srs2-deficient cells. We previously demonstrated that the association of Rad52 with Rad51 filaments is challenged at salt concentrations lower than those required to destabilize Rad51 filaments ([@bib13]). Therefore, we challenged the stability of Rad51 filaments by incubation with excess ssDNA (ɸX174 viral (+) strand). This experiment could not be done by EM, because the competing DNA hinders the spreading of Rad51 filaments on carbon grids. Rad51 filaments were formed by adding Rad51 with Rad52 or Rad52-Y376A on a 400nucleotides (nt)-long Cy5-labeled ssDNA pre-coated with RPA. The previously described optimal stoichiometric conditions were used with slight modifications ([@bib13]; see Materials and methods). Analysis of glutaraldehyde-fixed-protein complexes by agarose gel electrophoresis ([Figure 5---figure supplement 2a](#fig5s2){ref-type="fig"}) showed that Rad52-Y376A assembled Rad51 filaments as efficiently as WT Rad52. This confirmed our EM observation and our in vivo results that the Rad52-Rad51 interaction is not strictly required for Rad51 filament formation. After incubation at 37°C for 20 min to allow Rad51 filament formation, competing ɸX174 viral (+) strand was added to the reaction and incubated for an additional 30 min. Surprisingly, the stability of Rad51 filaments assembled with Rad52 or Rad52-Y376A was comparable ([Figure 5---figure supplement 2a](#fig5s2){ref-type="fig"}). We confirmed this result using a benzonase assay ([Figure 5---figure supplement 2b](#fig5s2){ref-type="fig"}). This suggested that losing the interaction between Rad52 and Rad51 does not affect the stability of Rad51 filaments. However, we previously showed by EM that only 10% of Rad51 filaments assembled on the same 400nt-long ssDNA are associated with more than one Rad52 spot ([@bib13]). Therefore, we cannot rule out that the amount of Rad52 associated with Rad51 filaments was too low to show an effect on stability in this assay and we cannot conclude on the effect of Rad52 on Rad51 filament stability.

Rad52 protects Rad51 filaments from Srs2 dismantling activity in vitro {#s2-8}
----------------------------------------------------------------------

To test whether Rad52 protects Rad51 filaments from Srs2 dismantling activity, we incubated Srs2 with Rad51 filaments assembled in vitro on ɸX174 ssDNA for 5 min, and analyzed the resulting nucleoprotein complexes by EM. As described previously ([@bib49]; [@bib24]), Srs2 efficiently disrupted Rad51 filaments when Rad51 was added prior to RPA. Only 11% of DNA molecules remained covered with Rad51 after 5 min of incubation with Srs2 ([Figure 5d](#fig5){ref-type="fig"}). Conversely, when Rad52 and Rad51 were added together on RPA-coated ssDNA, 90% of complete Rad52-associated Rad51 filaments were still present after 5 min of incubation with Srs2. This result clearly indicated that Rad52 protects Rad51 filaments from Srs2 dismantling activity. This protection was weakened when Rad51 filaments were formed in the presence of Rad52-P381S or Rad52-Y376A (only 60 and 14% of complete Rad51 filaments after 5 min).

As Srs2 also inhibits the φX174-based strand exchange reaction in vitro ([@bib49]), we used this assay to confirm Rad52 protective effect. Addition of 66 nM Srs2 was enough to inhibit the strand exchange reaction when Rad51 was added to ssDNA prior to RPA ([Figure 5e](#fig5){ref-type="fig"}). Conversely, when Rad52 was added with Rad51 on RPA-coated ssDNA, half of the products were still formed in the presence of the same concentration of Srs2. Double Srs2 concentration was required to efficiently inhibit the reaction in the presence of Rad52. Srs2-mediated inhibition was dependent on Rad52-Rad51 interaction because strand exchange catalyzed by Rad52-P381S was largely reduced.

Rad52 capacity to protect Rad51 filaments could be the consequence of a direct interaction with Srs2, and we found by pull-down assay that Rad52 and Srs2 interacted. This interaction was not affected by the *rad52-Y376A* mutation ([Figure 5f](#fig5){ref-type="fig"}). Moreover, Rad52 did not affect Srs2 ATPase activity ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). Altogether, these results suggest that the presence of Rad52 within Rad51 filaments controls Srs2, probably through a competition mechanism rather than by direct inhibition of the Rad51-catalyzed Srs2 translocase activity.

Discussion {#s3}
==========

Rad52 interaction with Rad51 is responsible for the toxicity of Rad51 filaments in Srs2-deficient cells {#s3-1}
-------------------------------------------------------------------------------------------------------

We previously showed that Rad52 is involved in the toxicity of Rad51 filaments in Srs2-deficient cells ([@bib13]). To understand the underlying mechanism, we conducted a *RAD52* gene mutation screen to identify mutations that could suppress the toxicity of Rad51 filaments without affecting their formation. Among the hits, we found several mutations in amino acid residues located within the Rad52 domain that contains an essential motif for its interaction with Rad51 ([@bib23]). The extended analysis of this domain by directed mutagenesis showed that there is a correlation between the impairment of the Rad52-Rad51 interaction by these mutations and their ability to suppress the Srs2-deficient cell phenotype. Specifically, *rad52-Y376A* restores resistance to DNA damage in *srs2*∆ homozygous diploid cells exposed to γ-rays as well as viability of *srs2*∆ haploid cells in which a HO-induced DSB is repaired by SSA. The *rad52-P381*S mutation, which affects the Rad52-Rad51 interaction less strongly than *rad52-Y376A*, is a weaker suppressor of the Srs2-deficient cells phenotype. The *rad52-Y376A* mutation also suppresses synthetic lethality induced in Srs2-deficient cells by mutations in genes involved in HR or in DNA replication. ChIP analyses confirmed that the impaired interaction between Rad52 and Rad51 does not affect Rad51 recruitment to ssDNA at DSB sites in Srs2-deficient cells. Thus, from these in vivo observations we infer that the suppression of the *srs2*∆ cell phenotype cannot be attributed to a lower mediator activity of Rad52-Y376A. In turn, this suggests that the potential toxicity of Rad51 filaments in Srs2-deficient cells is related to the association of Rad52 with Rad51 filaments. In agreement, our EM analysis of Rad51 filament assembly on φX174 ssDNA indicates that the association of Rad52-Y376A with Rad51 filaments is reduced compared with WT Rad52.

How does Rad52 association with Rad51 filaments lead to toxicity in the absence of Srs2? {#s3-2}
----------------------------------------------------------------------------------------

Surprisingly, we found that the *rad52-Y376A* mutation strongly impairs the interaction with Rad51 (co-immunoprecipitation and pull-down experiments), while it affects only partially the association of Rad52 with Rad51 filaments observed by EM. We hypothesize that this mutation affects mostly the interaction between protomers, which could be the most common interaction in the nucleus. On the other hand, the interaction with Rad51 filaments could be complex. Besides its interaction with Rad51 through the YEKFAP domain, Rad52 could associates with Rad51 filaments through DNA binding ([@bib32]), or via interaction with residual DNA-bound RPA. Moreover, the Rad52 FVTA motif, which is essential for binding to Rad51 ([@bib20]), could also be involved in the association of Rad52 with Rad51 nucleofilaments.

Similarly to what was proposed for the Rad51 paralogues SWS-1 in *Caenorhabditis elegans* ([@bib45]; [@bib31]) and Rad55/Rad57 in yeast ([@bib29]), we suggest that Rad52 could be involved in the stabilization of Rad51 filaments in vivo in yeast. Although we did not see any effect of the *rad52-Y376A* mutation on the stability of Rad51 filaments (ssDNA competition assay) or on protection against benzonase endonuclease activity, it is clear that this mutation suppresses Rad51 filament toxicity and rescues most of the phenotypes of Srs2-deficient haploids and diploids cells. It is possible that the toxic effect of Rad52 binding to Rad51 filaments requires the association with the yeast Rad51 paralogues Rad55/Rad57 and the SHU complex. Rad52-stabilized Rad51 nucleofilaments might lead to different disturbances that cause the toxicity observed in Srs2-deficient cells. For example, [@bib47] recently proposed that Rad51 has to be removed from ssDNA to allow de novo DNA synthesis to fill in the gaps formed during the SSA process. Rad52-mediated stabilization of Rad51 filaments could also favor the formation of branched toxic joint molecules upon ssDNA invasion at ectopic positions ([@bib12]).

The Rad51-binding domain of Rad52 is dispensable for Rad51 filament assembly in vivo {#s3-3}
------------------------------------------------------------------------------------

Rad52-Y376A can properly assemble Rad51 filaments on a 400nt-long ssDNA and is only slightly defective on φX174 ssDNA (5 kb in size). Our EM analysis showed that 70% of complete Rad51 filaments are formed in the presence of mutant Rad52, compared with 100% with WT Rad52 and 25% in its absence. However, our experiments confirmed that disturbing the interaction between Rad52 and Rad51 strongly affects the φX174 plasmid-based strand exchange reaction ([@bib23]). Rad52 association with Rad51 filaments might be required for strand exchange in vitro. In contrast, Rad52-Y376A promotes strand invasion efficiently in vivo as supported by the normal frequency of γ-ray- and HO-induced HR in *rad52-Y376A* mutant cells. Additionally, the weak sensitivity of *rad52-Y376A* cells to γ-rays and the lower recruitment of Rad51 on ssDNA after DSB formation in *rad52-Y376A* cells are both dependent on Srs2. We hypothesize that the different results obtained in vivo and in vitro might also be related to a compensatory effect in vivo by the Rad51 paralogues Rad55/Rad57 and SHU.

Rad52 protects Rad51 filaments from Srs2 dismantling activity {#s3-4}
-------------------------------------------------------------

The fact that the sensitivity of *rad52-Y376A* mutant cells to DNA damage depends on Srs2 suggests that Rad52 protects Rad51 filaments from Srs2 activity, a hypothesis that we confirmed in vitro. EM analysis and strand exchange reactions showed that Rad51 filaments are more resistant to Srs2 activity in the presence of Rad52. We hypothesized that Rad52 association with Rad51 filaments could mask the Rad51 interaction sites that are essential for Srs2 dismantling activity ([@bib38]). In agreement, excess of Rad52 can disrupt the Rad51-Srs2 interaction ([@bib38]). The physical interaction we found between Rad52 and Srs2 might have a synergic effect on Rad51 filament protection. Although we found that Rad52-associated Rad51 filaments do not lower Srs2 ATPase activity, Srs2 might idle when it interacts with Rad52 without stopping its ATPase activity.

It has been proposed that Rad55/Rad57 and the SHU complex protect Rad51 filaments from Srs2 activity ([@bib4]; [@bib29]). As they act as a functional ensemble with Rad52 ([@bib16]), it is possible that each member of such complex plays its part in Rad51 filament protection.

Interplay between Rad52 sumoylation and Srs2 in the control of Rad51 filament formation {#s3-5}
---------------------------------------------------------------------------------------

We previously showed that *SIZ2* overexpression drives massive sumoylation of Rad52 and leads to the suppression of Rad51 filament toxicity in Srs2-deficient cells ([@bib13]). Here, we found that impaired interaction between Rad52 and Rad51 has the same consequences. The finding that Cdc48 curbs the interaction between Rad52-SUMO and Rad51 ([@bib3]) links these two observations. We propose that massive sumoylation activates Cdc48. This, in turn, disengages Rad52 from Rad51 filaments, thus suppressing their potential toxicity in Srs2-deficient cells ([Figure 6a](#fig6){ref-type="fig"}). In WT cells, we suggest that destabilization of Rad51 filaments following Rad52 sumoylation is not fast enough and Srs2 is required to catalyze rapid Rad51 removal once Rad52 is dissociated to avoid the formation of toxic Rad51 filaments ([Figure 6b,c](#fig6){ref-type="fig"}). Massive sumoylation of Rad52 or enhanced dissociation of Rad52 by mutations might compensate for the slow kinetics of Rad51 destabilization in the absence of Srs2 activity.

![Interplay between Rad52 sumoylation and Srs2 in the control of Rad51 filament formation.\
(**A**) In Srs2-deficient cells, the association of Rad52 with Rad51 filaments is responsible for their potential toxicity. Massive sumoylation of Rad52 could trigger the Cdc48-dependent release of Rad52, as do mutations that affect the interaction between Rad52 and Rad51. Excessive stabilization of Rad51 filaments by Rad52 could block DNA synthesis or DNA damage tolerance (DTT) events and promote faulty HR events. (**B**) Impaired interaction between Rad52 and Rad51 would sensitize Rad51 filaments to Srs2 activity. (**C**) In WT cells, uncontrolled loading of Rad51 might lead to the production of toxic Rad51 filaments that are efficiently removed by Srs2. (**D**) Global view of Rad51 filament regulation during HR (see text for more details).](elife-32744-fig6){#fig6}

Our findings and these hypotheses lead us to propose a global model on the involvement of Rad52 and Srs2 in HR ([Figure 6d](#fig6){ref-type="fig"}). Rad52 would be associated with Rad51 filaments long enough to ensure their protection against Srs2 and the stability required to promote homology search. Once this process is achieved, events, such as joint formation, D-loop formation or DNA synthesis, would trigger Siz2-dependent Rad52 sumoylation. Cdc48 would then induce Rad52 dissociation, allowing Srs2 to remove Rad51 from ssDNA. Srs2 activity would be essential to allow subsequent steps to occur, such as DNA synthesis, or to displace Rad51 to avoid improper dsDNA invasion. Srs2 might also be required to displace the invading strand and to promote synthesis-dependent strand annealing ([@bib10]; [@bib27]). Rad52 release might also be important for Rad51 removal from dsDNA by the Rad54 and Rdh54 motor proteins ([@bib7]; [@bib30]).

Role of Rad52 in mammalian cells {#s3-6}
--------------------------------

While *RAD52* is essential for all homology-dependent repair in budding yeast, its role in mammalian cells has remained mysterious. Indeed, mice lacking RAD52 have a mild phenotype (for a review: [@bib28]), but RAD52 is required for the viability of BRCA2-deficient cells, the canonical RAD51 loader in human cells ([@bib14]). Recent studies revealed a role for RAD52 pairing activity in promoting DNA synthesis following replication stress ([@bib5]; [@bib41]). This role is independent from those of BRCA2 and RAD51. However, RAD52 capacity to interact with RPA and RAD51 suggests a role in RAD51 filament formation ([@bib33]; [@bib40]). Monitoring of RAD51 in U2OS cells depleted for the Cdc48 orthologue p97 and treated with zeocin shows a striking abnormal nuclear assembly of RAD51. Interestingly, these structures are strongly reduced by simultaneous depletion of RAD52, but barely by depletion of BRCA2. This suggests that BRCA2 is not primarily involved in RAD51 loading at these structures, but rather RAD52, like in yeast cells ([@bib3]). Similarly to the situation in yeast, Cdc48/p97 might be required to unload RAD52 that would otherwise stabilize these abnormal RAD51 structures. Therefore, like in yeast, mammalian RAD52 might be involved in RAD51 filament formation and stabilization in contexts that remain to be defined.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\        Designation                          Source or reference               Identifiers    Additional information
  or resource                                                                                                          
  ------------------------------ ------------------------------------ --------------------------------- -------------- ---------------------------------------
  Gene\                          *RAD52*                              NA                                SGD: YML032C   
  (*Saccharomyces cerevisiae*)                                                                                         

  Gene\                          *RAD51*                              NA                                SGD: YER095W   
  (*S. cerevisiae*)                                                                                                    

  Gene\                          *Srs2*                               NA                                SGD: YJL092W   
  (*S. cerevisiae*)                                                                                                    

  Genetic reagent\               viral (+) strand of φX174 DNA                                                         
  (*Bacteriophage φ-X174*)                                                                                             

  Strain, strain background\     FF18733                                                                               Cell line maintained\
  (*S. cerevisiae*)                                                                                                    in E. Coïc\'s lab

  Strain, strain background\     YFP17; JKM146                                                                         Cell line maintained\
  (*S. cerevisiae*)                                                                                                    in J. Haber\'s lab

  Antibody                       anti-Rad51 (rabbit polyclonal)       Abcam                             ab63798        

  Antibody                       anti-FLAG (Mouse polyclonal)         Sigma                             F3165          

  Antibody                       anti-DPS1 (Rabbit polyclonal)        S. Marcand\'s lab                                

  Antibody                       anti-RPA (Rabbit polyclonal)         V. Géli\'s lab                                   

  Antibody                       anti-Mouse IR800 Goat monoclonal)    Advansta                          R-05061--250   

  Antibody                       anti-Rabbit IR700 Goat monoclonal)   Advansta                          R-05054--250   

  Antibody                       anti-Mouse IR700 Goat monoclonal)    Advansta                          R-05055--250   

  Antibody                       anti-Srs2 (Goat polyclonal)          Santa-Cruz                        sc-11991       

  Recombinant DNA reagent        YCplac111-Rad52-6His-3FLAG           This study                                       progenitors: YCplac111\
                                                                                                                       (GenBank: X75457,\
                                                                                                                       L26350)

  Recombinant DNA reagent        Yiplac211-rad52-P381S;\              This study                                       progenitors: Yiplac211\
                                 Yiplac211-rad52-Y376A                                                                 (GenBank: X75462,\
                                                                                                                       L26358)

  Recombinant DNA reagent        pET15b-Rad52-FLAG                                                                     Progenitor: pET15b (addgene: 69661-3)

  Peptide, recombinant\          Rad52-FLAG                           This study                                       
  protein                                                                                                              

  Peptide, recombinant\          RPA                                  This study                                       
  protein                                                                                                              

  Peptide, recombinant\          Rad51                                This study                                       
  protein                                                                                                              

  Peptide, recombinant\          Srs2                                 This study                                       
  protein                                                                                                              

  Peptide, recombinant\          3XFLAG                               Sigma                             F4799          
  protein                                                                                                              

  Commercial assay or kit        GeneMorph II EZClone\                Agilent Technologies              200552--5      
                                 Domain Mutagenesis                                                                    

  Commercial assay or kit        Dynabeads coupled to Protein A       Invitrogen                        11041          

  Commercial assay or kit        Dynabeads coupled to PanMouse        Invitrogen                        10002D         

  Commercial assay or kit        Platinum SYBR Green\                 Invitrogen                        11733--046     
                                 qPCR SuperMix-UDG                                                                     

  Software, algorithm            PSI-Blast                            [@bib2]                                          

  Software, algorithm            Muscle                               [@bib11]                                         

  Software, algorithm            Jalview                              [@bib50]                                         

  Software, algorithm            iTEM software                        Olympus, Soft Imaging Solutions                  

  Software, algorithm            ImageQuant TL software               GE Healthcare Life Sciences                      
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

*S. cerevisiae* strains {#s4-1}
-----------------------

Strains used in this study are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. Experiments were mostly conducted in the FF18733 background. Diploid cells used in survival and recombination assays were the result of crosses between isogenic haploid strains bearing the *arg4*-RV and *arg4*-Bg frame-shift mutations. The mutations *rad52-P381S* and *rad52-Y376A* were introduced in yeast cells with the pop-in pop-out technique using the integrative plasmids Yiplac211-*rad52-P381S* and Yiplac211-*rad52-Y376A*.

Plasmids {#s4-2}
--------

The 6 His-3 FLAG tag was added in frame to *RAD52* in YCplac111 plasmids using the SLIC cloning method ([@bib25]).

Random mutagenesis {#s4-3}
------------------

The Rad52 random mutation library was obtained by PCR-directed mutagenesis of a Ycplac111 centromeric plasmid that carried the *RAD52* gene ([@bib35]). The GeneMorph II EZClone Domain Mutagenesis method (Agilent Technologies) was used according to the manufacturer\'s instructions to obtain a maximum number of plasmids bearing only one mutation in the *RAD52* gene. PCR products were amplified in *Escherichia coli*. The library was extracted and transformed in the *rad52*∆ *srs2*∆ strains directly plated on MMS- containing YPD plates for selection.

Directed mutagenesis {#s4-4}
--------------------

Single mutations were introduced in the desired plasmid using a PCR method adapted from [@bib17]).

Sequence alignment {#s4-5}
------------------

Homologous sequences of *S. cerevisiae* Rad52 were retrieved using PSI-Blast searches against the nr database ([@bib2]; [@bib37]). Multiple alignment of the full length sequences of these homologs was obtained using the Muscle software ([@bib11]). However, within the C-terminal disordered tail the algorithm did not satisfactorily align the small linear motifs that surround the Rad51 binding domain and the alignment had to be manually refined. The final alignment was represented using Jalview ([@bib50]).

Irradiation and measurement of recombination rates {#s4-6}
--------------------------------------------------

γ-ray irradiation was performed using a ^137^Cs source. After irradiation, exponentially growing cells were plated at the appropriate dilution on rich medium (YPD) to measure the survival rate, and on synthetic plates without arginine to quantify the number of HR events. For quantitation, the mean percentage of survival from at least three independent experiments is presented.

Survival following DSB formation {#s4-7}
--------------------------------

Cells were grown overnight in liquid culture medium containing lactate before plating. Survival following HO-induced DSB was measured as the number of cells growing on galactose-containing medium divided by the number of colonies growing on YPD. The results shown are the average of at least three independent experiments.

Co-immunoprecipitation {#s4-8}
----------------------

Extracts were prepared from cell cultures in exponential phase as previously described ([@bib42]) and resuspended in lysis buffer (50 mM Hepes KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 5% NP40) without DNase treatment. Whole cell extracts (1 mg) were incubated with 2 μg of a rabbit anti-Rad51 polyclonal antibody (Abcam) at 4°C for 1 hr. Then, 50 μl of Dynabeads coupled to Protein A (Invitrogen) was added, and the incubation continued for another hour. Immunoprecipitates were washed twice with 1 ml of lysis buffer and resuspended in 30 μl of 1X Laemmli buffer. Eluted proteins were analyzed by western blotting. Proteins were separated on 10% SDS-PAGE and transferred to Hybond-C Super membranes (Amersham Biosciences). Proteins were detected with a mouse anti-FLAG monoclonal (Sigma, 1/10,000), rabbit anti-Rad51 polyclonal (1/2000) or rabbit anti-DPS1 polyclonal antibody (1/30,000, a gift from S. Marcand). Blots were then incubated with monoclonal goat anti-mouse IR800 or goat anti-rabbit IR700 or IR800 secondary antibodies (1/10,000, Advansta). Protein-antibody complexes were visualized using the Odyssey CLx system (Li-cor Biosciences). The presence of Rad51 in the immunoprecipitated fractions could not be detected to validate the efficiency of the immunoprecipitation because it migrates at the same level as the anti-Rad51 IgG. However, the absence of Rad52 in the *rad51*∆ immunoprecipitates confirmed that the detected Rad52-FLAG signals were related to the Rad52-Rad51 interaction.

ChIP experiments and quantitative PCR analyses {#s4-9}
----------------------------------------------

Cells were grown in YPD until late exponential phase. After inoculation in 400 ml of YPLactate, cultures were grown to a concentration of 5 to 10 × 10^6^ cells/ml. A 50 ml sample was removed at the 0 hr time-point and then galactose was added to a final concentration of 2%. Incubation was continued and 50 ml samples were removed at different time-points. Cells were fixed with 1% formaldehyde, which was subsequently neutralized with 125 mM glycine. Cells were centrifuged and washed with TBS buffer (20 mM Tris pH8, 150 mM NaCl). Cell pellets were then frozen at −20°C. ChIP was carried out as previously described with minor modifications ([@bib43]). Samples were incubated with 2 µg of rabbit anti-RPA polyclonal (a gift from V. Géli), mouse anti-FLAG monoclonal (Sigma) or rabbit anti-Rad51 polyclonal antibody (Santa Cruz Biotechnology). 50μl of Magnetic Dynabeads Protein A or Pan Mouse (Invitrogen) was added to each sample. Following washes, protein elution and crosslink reversal, samples were incubated with proteinase K followed by DNA purification with the QIAquick PCR Purification Kit (Qiagen). The primers used for QPCR were EMO102 (CCC TGT GTG TTC TCG TTA TGT T) and EMO103 (TAA GGC GCC TGA TTC AAG A) for amplification at 0.6 kb from the DSB site, EMO65 (CCA AAT AGC CAA TGG TGT CA) and EMO66 (CCA AGA TGC AAA CCG AAT AA) for amplification at 7.6 kb from the DSB site, EMO100 (AGC AAA GTT GGG TGA AGT ATG GTA) and EMO101 (CAA ATT TGT CTA GTG TGG GAA CG) for amplification at the *ARG5,6* locus. Quantitative PCR reactions were performed using the Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen) and an Eppendorf Realplex system. ChIP relative enrichment was calculated as the ratio between the quantitative PCR values of the IP fraction and those of the input fraction.

Protein purification {#s4-10}
--------------------

Rad52-FLAG, Rad52-P381S-FLAG and Rad52-Y376A-FLAG were purified from *E. coli* BL21 (DE3) cells transformed with the respective pET15b-based plasmids. Cells were grown in 3 liters of LB broth with 100 µg/ml ampicillin at 37°C until A~600~ = 0.8. Protein expression was induced by addition of 1 mM IPTG followed by incubation at 30°C for 4 hr. Cells were lysed by sonication in 50 mM Tris-HCL pH 7.5, 10% sucrose, 150 mM KCl, 0.5 mM EDTA, 1 mM DTT, 1x complete protease inhibitor (Roche), 5 μg/ml chymostatin, 5 μg/ml pepstatin, 1 mM AEBSF and 0.1% NP40. Lysates were clarified by centrifugation and supernatants were precipitated with ammonium sulfate (50% saturation). Pellets were suspended in buffer Kc (20 mM KH~2~PO~4~ pH 7.4, 1X Complete protease inhibitor, 5 μg/ml chymostatin, 5 μg/ml pepstatin, 1 mM AEBSF, 500 mM KCl and 20 mM imidazole) and incubated with a saturating amount of Ni Sepharose High Performance Resin (GE Healthcare) at 4°C for 2 hr. The resin was washed with large volumes (100--150 ml) of buffer Kc. Proteins were eluted with buffer Kc containing 200 mM imidazole. The buffer was changed with a PD10 column (GE Healthcare) to buffer K (20 mM KH~2~PO~4~ pH 7.4, 1 mM DTT) containing 150 mM KCl. Next, proteins were loaded to a 1 ml Hi-trap heparin column (GE Healthcare) and eluted with a 10 ml gradient of 150--500 mM KCl in buffer K. The Rad52-containing fractions were pooled and the buffer changed to buffer K containing 120 mM KCl with a PD10 column. Proteins were loaded in a 1 ml RESOURCE Q column (GE Healthcare) and eluted through a 10 ml gradient of 120--500 mM KCl in buffer K. The Rad52-containing fractions were pooled, diluted to a final concentration of 200 mM KCl and glycerol was added (10% final concentration). Rad52 concentration was determined using an extinction coefficient of 30,495 mole/l/cm at 280 nm.

RPA was purified from the protease-deficient yeast strain BJ5496 (*ura3-52*, *trp1*, *leu2∆1*, *his3∆200*, *pep4::HIS3*, *prb∆1.6R*, *can1*, *GAL*). Cells were transformed with three plasmids that carried the *RFA1*, *RFA2*, or *RFA3* ORF under the control of a GAL promoter (a gift from R. Kolodner). The RPA heterotrimer was purified as described ([@bib21]). Rad51 was overexpressed in *E. coli* BL21 (DE3) pLysS cells transformed with the pEZ5139 plasmid (provided by S. Kowalczykowski) and then purified as described previously ([@bib52]). His-tagged Srs2 (N-terminal) was purified from sf9 cells infected with a recombinant baculovirus ([@bib49]).

Pull-down assay {#s4-11}
---------------

The interaction between Rad52 and Rad51 was assayed in vitro by incubating 80 nM Rad52-FLAG with 0.25 μg of a goat monoclonal anti-FLAG antibody in the same lysis buffer used for co-immunoprecipitation (in the presence of 40 or 140 mM NaCl), at 4°C for 30 min. Then 10 μl of Dynabeads Pan Mouse IgG (Invitrogene) were added and the incubation was continued for 1 hr. Beads were washed with lysis buffer. After addition of 5nM Rad51, the incubation was continued at 4°C for 1 hr. Samples were washed twice with lysis buffer and elution was performed by addition of 0.1 mg/ml 3XFLAG peptide (Sigma) at 30°C for 30 min. Proteins were analyzed by SDS-PAGE. Rad52-FLAG and Rad51 were detected with specific antibodies as for co-immunoprecipitation.

The interaction between Rad52 and Srs2 was assayed in vitro by incubating 4 nM Rad52-FLAG and 4 nM Srs2 with 0.5 μg anti-FLAG antibody in buffer P (25 mM Tris HCl pH 7.5, 10 mM magnesium acetate, 1 mM DTT, 90 mM NaCl, 10% glycerol, 0.05% NP40) at 25°C for 90 min. 12.5 μl of Dynabeads Pan Mouse IgG were then added to the mixture and incubated at 25°C for another 90 min. Beads were washed twice with buffer P. Pulled down proteins were eluted by boiling at 95°C in 1x Laemmli. Proteins were separated in SDS PAGE and Rad52 was revealed as described previously. Srs2 was detected with a goat anti-Srs2 polyclonal antibody (Santa Cruz, 1/2000) and with a secondary anti-goat IR800 antibody (Advansta, 1/10,000).

Electrophoretic mobility shift assay {#s4-12}
------------------------------------

Increasing amounts of WT and mutant Rad52-FLAG were incubated with 0.27 µM 5\' end-Cy5-labeled XV2 oligonucleotide (5\'-TGG GTG AAC CTG CAG GTG GGC AAA GAT GTC CTA GCA ATG TAA TCG TCA AGC TTT ATG CCG TT-3\') in buffer E (10 mM Tris-HCl pH 8, 5 mM MgCl~2~, 100 mM NaCl) at 37°C for 10 min. Complexes were separated on 8% native polyacrylamide gels. This experiment was also done with dsDNA obtained from annealing XV2 with the complementary sequence.

DNA annealing {#s4-13}
-------------

Reactions were performed with 200 nM Cy5-labeled Oligo 25 and 200 nM Oligo 26, two 48-nucleotide-long complementary primers described in ([@bib51]). Each oligonucleotide was incubated without proteins, with 30 nM RPA or with 134nM Rad51 at 30°C for 5 min, before addition of 40 nM of WT or mutated Rad52. An aliquot of the reaction was collected every 2 min and transferred to stop buffer (20 μM unlabeled Oligo 25, 0.5% SDS, 0.5 mg/ml proteinase K). Samples were separated on 8% native TBE polyacrylamide gels. Fluorescent signals were revealed with a Typhoon 9400 scanner and quantified with the ImageQuant TL software.

Electron microscopy analysis {#s4-14}
----------------------------

For transmission electron microscopy studies, a fraction of the following Rad51 filament formation reactions were used. Standard reactions were done by incubating 15 µM (nucleotides) viral (+) strand of φX174 DNA with 5 µM Rad51 in a buffer containing 10 mM Tris-HCl pH 7.5, 40 mM KCl (or 140 mM KCl when specified), 3 mM MgCl~2~, 1 mM DTT and 2 mM ATP at 37°C for 3 min. Then, 0.5 μM RPA was added for 5 min. For filament formation in the presence of Rad52, 15 μM φX174 ssDNA was incubated with 1.5 μM saturated RPA at 37°C in the same buffer for 5 min before addition of 5 μM Rad51 and 1 μM Rad52 at 37°C for 20 min. Partial Rad51 filaments range from 1500 to 2500 nm while the size of complete Rad51 filaments is 2800 nm. Srs2 dismantling effect was tested by adding 200 nM Srs2 and 1 mM ATP to the Rad51 filament formation reaction at 37°C for 5 min. Of each reaction, 5 μl was deposited onto a 600 mesh copper grid coated with a thin carbon film, previously activated by glow-discharge in the presence of pentylamine (Merck, France). After 1 min, grids were washed with aqueous 2% (w/v) uranyl acetate (Merck, France) and then dried with ashless filter paper (VWR, France). Observations were carried out using a Zeiss 902 transmission electron microscope in filtered annular dark field mode. Images were acquired with a Veletta digital camera and the iTEM software (Olympus, Soft Imaging Solutions).

DNA strand exchange reaction {#s4-15}
----------------------------

30 µM (nucleotides) viral (+) strand of φX174 DNA were coated first with 3.3 µM RPA by incubation in SEB buffer (42 mM MOPS pH 7.2, 3 mM Mg acetate, 1 mM DTT, 20 mM KCl, 25 µg/ml BSA and 2.5 mM ATP) in a final volume of 12.5 μl at 37°C for 10 min. Rad51 filament formation was initiated by adding 10 μM Rad51 and 15 μM WT or mutated Rad52, or storage buffer as control, at 37°C for 20 min. Then, addition of 30 μM (nucleotides) of PstI-linearized φX174 dsDNA and 4 mM spermidine initiated the strand exchange reaction. After incubation at 37°C for 90 min, samples were deproteinized by addition of 2 μl of 10 mg/ml proteinase K, 5% SDS solution at 37°C for 10 min and analyzed by electrophoresis (0.8% agarose gels in 1x TAE buffer). Standard reactions were done by adding Rad51 prior to RPA. Gels were stained with ethidium bromide and fluorescent signals were imaged with a Typhoon 9400 scanner and quantified with the ImageQuant TL software. The ratio of nicked circular product was calculated as the ratio between the sum of the linear dsDNA substrate and the nicked circular product.

Challenging Rad51 filament with excess amounts of DNA {#s4-16}
-----------------------------------------------------

Rad52-catalyzed Rad51 filament formation was performed as follow. 165 nM RPA (1:15 nt) was incubated with 2.5 μM of 400nt-long ssDNA (5\' end-Cy5-labeled) in SEB buffer (final volume of 10 μl) at 37°C for 10 min. After addition of 1.2 μM Rad51 (1:2 nt) and 165nM Rad52 or Rad52-Y376A (1:15 nt), reactions were incubated at 37°C for 20 min. Then, ɸX174 viral (+) strand (from 5 to 12.5 μM) was added and incubated at 37°C for 30 min. Finally, after fixation with 0.25% glutaraldehyde, 4 μl of 40% sucrose was added to facilitate loading on 0.5% agarose gel. After electrophoresis in 1X TAE buffer at 100V for 1.5 hr, the fluorescent signals were imagined with a Typhoon 9400 scanner.

Benzonase assay {#s4-17}
---------------

Rad52-catalyzed Rad51 filaments were formed as described above. Nucleofilaments were then incubated with benzonase (from 0 to 1.25 units) and 2 mM MgOAc at 30°C for 20 min. Reactions were stopped by incubation with 0.5% SDS and 0.5 mg/ml proteinase K at 37°C for 15 min. Deproteinized ssDNA samples were run on 1% agarose gel in 1x TAE buffer at 100 V for 1 hr. Fluorescent signals were revealed with a Typhoon 9400 scanner.

Measurement of Srs2 ATPase activity {#s4-18}
-----------------------------------

ATPase assays were performed in strand exchange conditions with modifications in protein concentrations. 0.5 μM RPA was first incubated with 5 µM (nucleotides) viral (+) strand of φX174 DNA in 100 μl SEB buffer at 37°C for 10 min. 1.7 μM Rad51 and 0.33 μM Rad52 were then added and samples were incubated at 37°C for 20 min to allow Rad51 filament formation. Standard reactions were done by adding Rad51 prior to RPA. The addition of 50 nM Srs2 and an ATP regeneration system (20 U/ml pyruvate kinase, 20 U/ml lactate deshydrogenase, 0.4 mg/ml NADH) initiated the ATP hydrolysis reaction. Absorbance at 340 nm was measured at 37°C using a microplate spectrophotometer (CLARIO Star, BMG LABTech) every 2 min for 20 min. ATP hydrolysis was expressed as the ratio between the absorbance at 340 nm at a given time and the absorbance measured before Srs2 addition.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Rad52 association with Rad51 filaments is crucial to avoid their disruption by the Srs2 DNA translocase\" for consideration by *eLife*. Your article has been reviewed by by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Jessica Tyler as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In yeast, the Rad52 protein has a recombination mediator function to load Rad51 on RPA-coated ssDNA, which facilitates recombination. In contrast, the Srs2 helicase disrupts the Rad51 filaments and served as \"anti-recombinase\" to remove unscheduled recombination intermediates. In this study, Ma et al., screen for mutants of the Rad52 protein that are able to suppress the MMS sensitivity of Srs2-deficient cells as a way to explore the role of Rad52 in Rad51 filaments in DSB repair and how this relates with Srs2 function. Surprisingly, the authors find mutations in the FAP and YEKF domains of Rad52, which are known to impair Rad52 binding to Rad51, among those suppressors. The study is focused in two of the mutants selected, rad52-P381S and rad52-Y376A with different degrees of suppression. Based on genetic and biochemical analysis of these rad52 mutants, including EM analysis of Rad51 filaments, Ma et al. concluded that Rad51-Rad52 association is important for the protection of Rad51-filament against Srs2 helicase that dismantles Rad51 filament in an ATPase dependent manner.

The Rad52\'s role in a post-assembly step of Rad51 filament by the filament stabilization is an important conclusion, since the role of Rad52 to promote the formation of Rad51 filament as a mediator in pre-assembly step is believed to be a main function of Rad52 for Rad51-dynamics in the recombination. Indeed, a similar role to protect Rad51 filament against Srs2 helicase has been reported to Rad55-57 complex by W. Heyer\'s group. The authors also provide evidence favoring that Rad52-Rad51 interaction promotes the mediator function, and that the role of the 51-52 interaction goes beyond protection against Srs2, which should be properly discussed. Although most results are convincing and the conclusions relevant, few issues should be addressed to get further mechanistic insight on how Rad52 stabilizes Rad51-filaments on ssDNA.

Essential revisions:

\- Different results in this paper argue against the conclusion that \"the interaction between Rad52 and Rad51 is not required for Rad51 filament assembly, but for preventing Rad51 filament disassembly by Srs2\": (a) the SSA assay (Figure 4A) showing that cells lacking srs2 are impaired in SSA because Rad51 filaments are more stable, and that P381S and Y376A Rad52 mutants (in srs2Δ) rescues SSA because they reduce the stability/formation of Rad51 filaments, demonstrates that the mutations have a phenotype in the absence of Srs2, and the effect of the Rad51-Rad52 interaction is therefore not specific to protection from Srs2; (b) the Rad52-Y376A mutant accumulates more RPA and less Rad51 as shown by ChIP (Figure 5), and is severely impaired in strand exchange (Figure 6C), consistent with a Rad51-Rad52 interaction for the mediator role, and (c) if the interaction of Rad51-Rad52 were not important for HR but to prevent filament disassembly by Srs2, it would be necessary to explain why Rad52 P381S and Y376A mutants have such a strong phenotype without Srs2 (Figure 4B), The manuscript should be therefore rewritten to acknowledge these points.

\- Do the Rad51 Y376A or P381S mutations affect interaction with the Rad51 filament? This could be tested by performing pulldowns with biotinylated oligonucleotides pre-bound with Rad51. The assay should also be used to directly test the effect of Rad52 on the protection of Rad51 filaments from disruption by Srs2 (e.g., see Figure 2 in Liu et al., 2011) by preparing Rad51 filaments on ssDNA, without or with Rad52, and challenging it with Srs2 or e.g. DNAseI. This will dissect whether the effect is Srs2-specific, or whether Rad52 stabilizes the Rad51 nucleoprotein filament.

\- Most interactions of Rad52 mutant proteins with Rad51 had been tested in the presence of 140mM NaCl (Figure 2). However, EM analysis (in the presence of 40 mM KCl) clearly showed that Rad52 mutant proteins associate with Rad51 filaments to the similar extent to the wild-type Rad52 protein (Figure 6B). This discrepancy should be clarified by doing IP or pull-down experiments under the same condition for EM analysis and vice versa.

\- Although Rad52 stabilizes Rad51 filaments against the translocase activity of Srs2, it is important to show biochemically Rad52 indeed stabilizes Rad51 filament even in the absence of Srs2 by examining the effect of Rad52 on Rad51 filament by high salt attack or challenging by excess amounts of ssDNAs (with ATP turnover). This can be easily tested by analyzing Rad51 filaments by EM or by measuring ATPase activity of Rad51. This approach would also reveal a mechanism on how Rad52 stabilizes Rad51 even in the absence of Srs2.

\- Although Rad52 does not inhibit ATPase activity of Srs2, it is important to show that Rad52 by itself does not inhibit the helicase activity of Srs2, given that Rad52 and Srs2 interacts with each other.

\- The ChIP-qPCR shown in Figure 5 for Rad52 seems to have been performed with a Rad52-FLAG. Since the authors are analyzing two specific mutants for Rad52, it seems that they are detecting is a WT copy of Rad52 carrying FLAG, so that the mutant rad52 proteins are not detected. Those experiments need to be explained better how they were performed. If the authors are detecting only wt Rad52, this needs to be discussed. It is unclear what would be meaning of those data because authors are not detecting the mutant Rad52, subject of study. The results as such are confusing and needs to be clarified.

\- It is a bit surprising to use a SSA system that does not allow for identification of recombinants by a genetic selection of Leu2+ recombinants. However, authors should try to determine recombination via qPCR in the SSA assay used in Figure 4. It would be nice to see whether in the srs2 rad52-P381S and srs2 rad52-Y376S mutants the frequency of recombination accompanies the data of survival.

10.7554/eLife.32744.026

Author response

> Summary:
>
> In yeast, the Rad52 protein has a recombination mediator function to load Rad51 on RPA-coated ssDNA, which facilitates recombination. In contrast, the Srs2 helicase disrupts the Rad51 filaments and served as \"antirecombinase\" to remove unscheduled recombination intermediates. In this study, Ma et al., screen for mutants of the Rad52 protein that are able to suppress the MMS sensitivity of Srs2-deficient cells as a way to explore the role of Rad52 in Rad51 filaments in DSB repair and how this relates with Srs2 function. Surprisingly, the authors find mutations in the FAP and YEKF domains of Rad52, which are known to impair Rad52 binding to Rad51, among those suppressors. The study is focused in two of the mutants selected, rad52-P381S and rad52-Y376A with different degrees of suppression. Based on genetic and biochemical analysis of these rad52 mutants, including EM analysis of Rad51 filaments, Ma et al. concluded that Rad51-Rad52 association is important for the protection of Rad51-filament against Srs2 helicase that dismantles Rad51 filament in an ATPase dependent manner.
>
> The Rad52\'s role in a post-assembly step of Rad51 filament by the filament stabilization is an important conclusion, since the role of Rad52 to promote the formation of Rad51 filament as a mediator in pre-assembly step is believed to be a main function of Rad52 for Rad51-dynamics in the recombination. Indeed, a similar role to protect Rad51 filament against Srs2 helicase has been reported to Rad55-57 complex by W. Heyer\'s group. The authors also provide evidence favoring that Rad52-Rad51 interaction promotes the mediator function, and that the role of the 51-52 interaction goes beyond protection against Srs2, which should be properly discussed. Although most results are convincing and the conclusions relevant, few issues should be addressed to get further mechanistic insight on how Rad52 stabilizes Rad51-filaments on ssDNA.

Thank you for the nice summary. We present below our arguments to defend the three major points of the paper:

1\) Rad52-Rad51 interaction is responsible for "Rad51 filament toxicity" in Srs2deficient cells because disruption of Rad51 binding domain in Rad52 restores MMS resistance in Srs2-deficient cells.

2\) Rad52-Rad51 interaction is not essential for Rad51 filament assembly.

3\) In Srs2-proficient cells, the Rad52/Rad51 interaction protects the Rad51 filament against disassembly by Srs2.

We understand that our arguments were not explicit enough and consequently, we have made substantial modifications to the manuscript that are shown in blue in the revised text. We decided to add some technical descriptions of our experiments in an annex to this letter, to ease the reading of our answers to your comments.

> Essential revisions:
>
> \- Different results in this paper argue against the conclusion that \"the interaction between Rad52 and Rad51 is not required for Rad51 filament assembly, but for preventing Rad51 filament disassembly by Srs2\": (a) the SSA assay (Figure 4A) showing that cells lacking srs2 are impaired in SSA because Rad51 filaments are more stable, and that *P381S* and *Y376A* Rad52 mutants (in srs2Δ) rescues SSA because they reduce the stability/formation of Rad51 filaments, demonstrates that the mutations have a phenotype in the absence of Srs2, and the effect of the Rad51-Rad52 interaction is therefore not specific to protection from Srs2;

We agree with the statement in (a) that there is a role for Rad52 that is not specific to the protection from Srs2. As stated in the last paragraph of the Introduction, we found previously that Rad52 is at the origin of Srs2-deficient cell MMS sensitivity, possibly through the interaction with Rad51 nucleoprotein filaments. We hypothesized that this association confers an excessive stability to Rad51 filaments in Srs2-deficient cells. We have defined such filaments as toxic, because they are responsible for MMS sensitivity in Srs2-deficient cells. In the present work, we designed a genetic screen to identify Rad52 mutations that suppress MMS sensitivity and consequently Rad51 filament toxicity in Srs2-deficient cells. In the first part of the Results section, we report that with this screen, we identified mutations in the Rad51 binding domain. This finding confirmed that the interaction between Rad52 and Rad51 is responsible for Rad51 filament toxicity in Srs2-deficient cells. Therefore, we conducted a mutational analysis of the Rad51 binding domain (second and third part of the Results section) to confirm this link. The finding that the stronger suppressor phenotype can be attributed mostly to mutations that affect the interaction between Rad52 and Rad51 confirmed this link. In conclusion, Rad52 is responsible for the death of Srs2-deficient cells following exposure to MMS or γ-rays, because of its interaction with Rad51.

As underlined by the reviewers, we found that the Rad52-P381S and Rad52-Y376Amutants also rescue SSA in Srs2-deficient cells. In the first part of the Discussion section, we propose that the interaction between Rad52 and Rad51 is responsible for the toxicity of Rad51 filaments at the HO-induced DSB site in Srs2-deficient cells. Therefore, Rad52 would have at least two functions that are Srs2-independent: (i) displacement of RPA to mediate Rad51 filament formation, and (ii) stabilization of Rad51 filaments, which is the cause of their toxicity in the absence of Srs2. Nevertheless, we agree that we have not underlined enough the involvement of Rad52 in Rad51 filament toxicity in several parts of the paper, which could be misleading. For clarification, we modified the Abstract, the last paragraph of the Introduction section, and the Results section. We cannot introduce this notion in the Title because of character restrictions, but we added the idea that Rad52-Rad51 is facultative to filament formation, which is another conclusion about the Srs2-independent functions of Rad52 (see next section).

> \(b\) The Rad52-Y376A mutant accumulates more RPA and less Rad51 as shown by ChIP (Figure 5), and is severely impaired in strand exchange (Figure 6C), consistent with a Rad51-Rad52 interaction for the mediator role.

About point (b), the reason we claim that the Rad52-Rad51 interaction is not essential to the formation of Rad51 filaments is based on several results we think it is important to summarize here before considering the ChIP experiment addressed by the reviewers. As explained in the Abstract and in the first two parts of the Results section, the double mutants *rad52-P381S srs2*∆ and *rad52-Y376A srs2*∆ are not sensitive to MMS or γ-ray irradiation (Figure 1). This shows thatMMS and γ-ray sensitivity in the *rad52-P381S* and *rad52-Y376A* single mutants are dependent on Srs2 activity. When Srs2 is depleted, the loss of interaction between Rad52 and Rad51 (as observed by co-IP and pull-down experiments) does not impact HR sufficiently to impair repair. Actually, measurement of γ-ray-induced HR frequencies in the recombination system between heteroalleles of the *ARG4* gene (Figure 3 and subsection "Rad52 interaction with Rad51 is dispensable for gene conversion") shows that HR is not affected in the mutants. In addition, we observed that repair by gene conversion of a HO-induced DSB is not significantly affected by *rad52-P381S* and *rad52-Y376A* (now in Figure 3). Altogether, these results strongly suggest that both Rad52 mutants, despite the weak interaction with Rad51, form Rad51 filaments. This notion is now added in the Title. It is true that other regions that would bind to Rad51 (even very weakly, according to the faint interaction we observed with the *rad52-Y376A* mutant even when pull-down assays were performed with 40mM NaCl) could help the loading of the protein. We added a comment in subsection "The *rad52-Y376A* and *rad52-P381S* mutations impact the interaction between Rad52 157 and Rad51" to underline this point. The domains that could be involved in the association of Rad52-Y376A with Rad51 filaments are discussed in the Discussion section. Nevertheless, the Srs2-independent role of Rad52 is related to the stability and not to the formation of Rad51 filaments.

Concerning the ChIP experiments (Figure 5), it is true that the *rad52-Y376A* mutant accumulates more RPA and less Rad51, as it was explained in the Results section. Two hypotheses can be made from this observation. The first one is that *rad52-Y376A* is not able to normally assemble Rad51 filaments. The second proposes that according to the genetic relationship we observed between *srs2*∆ and *rad52-P381S* and *rad52-Y376A*, Srs2 removes more efficiently Rad51 filaments because they are less protected by the Rad52 mutants. We observed that in *rad52P381S srs2*∆ and *rad52-Y376A srs2*∆ double mutants, Rad51 is recruited at similar levels as in *srs2*∆ cells. This demonstrates, first, that Srs2 activity is responsible for the reduction in Rad51 recruitment in Rad52 mutants and, secondly, that both Rad52 mutants can form Rad51 filaments as efficiently as in WT, if Srs2 is depleted. To make this conclusion clearer, we modified the text in subsection "Rad52 interaction with Rad51 is dispensable for Rad51 filament formation at a HO-212 induced DSB but is essential for preventing Rad51 filament disassembly by Srs2" to develop this demonstration better.

As mentioned by the reviewers, it is true that the Rad52-Y376A mutant is severely impaired in strand exchange (now Figure 5C). This point is mentioned in the Results section. However, the reviewers have not compared this result with our observation that Rad52-Y376A forms Rad51 filaments on RPA-covered ssDNA (now Figure 5A). The mediator activity of the mutant protein is robust because 15 min incubation of Rad52-Y376A with Rad51 on RPA-covered ssDNA leads to the formation of 70% of complete Rad51 filaments, compared to 100% with the WT protein and 25% in the absence of Rad52 in the reaction. We cannot explain why this large amount of complete Rad51 filaments cannot achieve strand invasion and we discussed this point in the Discussion section. However, it is important to keep in mind that, as discussed above, Rad52-Y376A forms enough Rad51 filaments in vivo to ensure proper DNA repair after MMS and γ-rays irradiation or HO-induced DSB formation. We also added to the Discussion section that the Rad51 paralogues Rad55/Rad57 and SHU can compensate the effect of the mutation in vivo.

> \(c\) If the interaction of Rad51-Rad52 were not important for HR but to prevent filament disassembly by Srs2, it would be necessary to explain why Rad52 *P381S* and *Y376A* mutants have such a strong phenotype without Srs2 (Figure 4B), The manuscript should be therefore rewritten to acknowledge these points.

About point c), the strong phenotype of the double mutants *rad52-P381S srs2*∆ and *rad52-Y376A srs2*∆ observed in Figure 4B cannot be attributed to an inability of the Rad52 mutant proteins to assemble functional Rad51 filaments. As explained in the Results section, the new Figure 3B shows that the *rad52-P381S* and *rad52-Y376A* mutant cells are not defective for the repair of a HO induced DSB at the *MAT* locus by gene conversion. Gene conversion absolutely requires the formation of Rad51 filaments to invade the donor sequence. Therefore, the only possible explanation for the finding that these two Rad52 mutants show only a slight decrease in viability after HO cut (not statistically significant for the *rad52-P381S* and barely significant for the *rad52-Y376A* mutant) is that Rad51 filaments are formed at the DSB site, which is observed at another locus in our ChIP experiments. However, viability of Srs2-deficient cells is very low after HO-induction in the gene conversion system. As explained in the Results section, this strong lethality has been described before (Ira et al., 2003). In Srs2-deficient cells, a large number of recombination events happening through the SDSA pathway are not resolved properly, leading to cell death. It is this defect that also leads to lethality in cells harboring the double *rad52-P381S srs2*∆ and *rad52-Y376A srs2*∆ mutations. If *rad52-Y376A srs2*∆ double mutant cells were sensitive to the HO-induced DSB because Rad52-Y376A cannot assemble Rad51 filaments, then, *rad52-Y376A* cells also would be sensitive to DSB formation. This is not the case. Moreover, the *rad52-P381S* or *rad52-Y376A* mutants do not reduce γ-ray-induced HR, as measured in the *ARG4* system (Figure 3).

In summary, it seems that the way we presented our data was confusing because major conclusions were not understood. Consequently, we introduced major changes in the organization of the Results section. First, at the end of the second chapter, we explained the assumptions that can be made from our first results. Second, we grouped our two gene conversion assays together (*ARG4* and *MAT*) because they both show that the *rad52-P381S* and *rad52-Y376A* mutations do not affect gene conversion (Figure 3). Then, we decided to present directly the ChIP experiments because they confirm at the molecular level that the *rad52-P381S* and *rad52-Y376A* mutant cells can assemble Rad51 filaments in Srs2deficient cells. Finally, we present the results obtained with the SSA system. By presenting the ChIP experiments before the SSA system results, it is easier for the reader to understand that the rescue of the *srs2*∆ phenotypes by the Rad52 mutations is not related to a default in Rad51 filament formation, but more certainly to the destabilization of Rad51 filaments in vivo by the loss of Rad52-Rad51 interaction.

> \- Do the Rad51 *Y376A* or *P381S* mutations affect interaction with the Rad51 filament? This could be tested by performing pulldowns with biotinylated oligonucleotides pre-bound with Rad51. The assay should also be used to directly test the effect of Rad52 on the protection of Rad51 filaments from disruption by Srs2 (e.g., see Figure 2 in Liu et al., 2011) by preparing Rad51 filaments on ssDNA, without or with Rad52, and challenging it with Srs2 or e.g. DNAseI. This will dissect whether the effect is Srs2-specific, or whether Rad52 stabilizes the Rad51 nucleoprotein filament.

In the original version of the manuscript, we counted the number of WT and mutated Rad52 molecules observed by EM on in vitro assembled Rad51 filaments (previous Figure 6B). This experiment shows a significant decrease in the average number of mutated Rad52 associated with the filaments (now Figure 5B). We now present this result in a clearer way in the text (subsection "in vitroanalysis of Rad52 activities when interaction with Rad51 is altered") and we changed the representation of our data on the graph.

We agree that pulldown assays could have provided useful information on Rad52 effect on Rad51 filaments. However, a series of technical problems did not allow us to obtain results, despite several attempts to optimize the assay (see annex for technical details). Consequently, we assessed the role of Rad52 on Rad51 filaments formed on 400nucleotides (nt)-long ssDNA by using a gel shift assay we described before (Esta et al., 2013), to avoid the use of streptavidin beads. In fact, we did several preliminary experiments before submitting the original version of the manuscript, but we were not convinced that this assay would allow testing correctly the role of Rad52 when associated with Rad51 filaments. Indeed, we observed previously by EM that only 10% of complete Rad51 filaments were associated with more than one Rad52 spot (Esta et al., 2013). Therefore, we worried that experiments designed to study Rad52 effect on Rad51 filaments with this assay would be difficult to interpret. Anyway, following your suggestions, we decided to carry out several experiments to test whether we could obtain some positive data. These results are described below in the section concerning Rad51 filament stability because several questions overlap.

> \- Most interactions of Rad52 mutant proteins with Rad51 had been tested in the presence of 140mM NaCl (Figure 2). However, EM analysis (in the presence of 40 mM KCl) clearly showed that Rad52 mutant proteins associate with Rad51 filaments to the similar extent to the wild-type Rad52 protein (Figure 6B). This discrepancy should be clarified by doing IP or pull-down experiments under the same condition for EM analysis and vice versa.

This is a very good point. Consequently, we performed EM analysis in the presence of 140mM NaCl and pull-down assays in the presence of 40mM NaCl. We found that a light interaction could be observed by pull-down assay at this low salt concentration, and that Rad52-Y376A still interacts with Rad51 filaments at high salt concentration (43% of WT). These results were added to the manuscript and discussed.

> \- Although Rad52 stabilizes Rad51 filaments against the translocase activity of Srs2, it is important to show biochemically Rad52 indeed stabilizes Rad51 filament even in the absence of Srs2 by examining the effect of Rad52 on Rad51 filament by high salt attack or challenging by excess amounts of ssDNAs (with ATP turnover). This can be easily tested by analyzing Rad51 filaments by EM or by measuring ATPase activity of Rad51. This approach would also reveal a mechanism on how Rad52 stabilizes Rad51 even in the absence of Srs2.

To answer these questions, as well as the previous remarks concerning the potential effect of the *rad52-P381S* and *rad52-Y376A* mutations on Rad52 interaction with Rad51 filaments, we analyzed Rad51 filament formation on 400nt-long ssDNA using a gel shift assay. First, we showed that Rad52-Y376A could assemble Rad51 filaments despites its poor association with Rad51, confirming our EM observation on PhiX174 DNA. This is now shown in Figure 5---figure supplement 2A and is also detailed in subsection"in vitroanalysis of Rad52 activities when interaction with Rad51 is altered".

We agree that it is important to test whether Rad52 can stabilize Rad51 filaments in vitro. However, this cannot be addressed simply by high salt attack because we published earlier that Rad52 is displaced at the low salt concentrations to which the Rad51 filament is not sensitive (Esta et al., 2013). This was confirmed here by the EM analysis of Rad51 filament formation. WT Rad52 is already strongly displaced from filaments in the presence of 150mM NaCl. Therefore, we decided to challenge Rad51 filaments by using excess amounts of ssDNA. Unfortunately, this experiment cannot be done by EM, because the competing DNA hinders the spreading of Rad51 filaments on carbon grids. Consequently, we set up experiments using our previously described gel shift assay (Esta et al., 2013). We challenged filaments with an excess of ssDNA (we used PhiX174 ssDNA at concentration 2 to 5fold higher than that of 400nt-long ssDNA). We found no difference in the stability of Rad51 filaments assembled with WT Rad52 or Rad52-Y376A (Figure 5---figure supplement 2A). We also performed experiments with benzonase (Figure 5---figure supplement 2B), but again, we did not see any difference between Rad51 filaments assembled with Rad52 or Rad52-Y376A. As our EM observations show that only 10% of Rad51 filaments are associated with more than one Rad52 spot, it is difficult to reach a conclusion. We now explain that our result might indicate that Rad52 cannot stabilize Rad51 filaments or that there is not enough Rad52 associated with Rad51 in these experiments. It is important to remember that Rad52 concentration cannot be increased in these experiments because it results in an inhibition of Rad51 filament formation. We also tested Rad51 filament stability by measuring Rad51 ATPase activity using the assay described in Li et al., (2007). No ATPase activity difference was observed between Rad51 filament formed with WT or mutated Rad52. Therefore, we found no way to address the question of the stabilization of Rad51 filaments by Rad52 by biochemical assays. We present this problem in the text, and this justifies the use of PhiX DNA, which is larger (5 kb), to test the effect of the Rad52 mutations on Rad51 filament formation and protection against Srs2. Effectively, the EM observation of Rad51 filaments formed with the mutated proteins shows undoubtedly that Rad52-Y376A can assemble Rad51 filaments and that Rad52 protects Rad51 filaments from Srs2 translocase activity.

Concerning the effect of the Y376A and P381S mutations on Rad52 association with the Rad51 filament, we cannot address this question with the gel shift assay. Previously, we showed by western blot analysis of the different nucleoprotein complexes separated on agarose gels that Rad52 could be detected on complete Rad51 filaments (Esta et al., 2013). We could do this using an anti-Rad52 polyclonal antibody provided by Stephen Jentsch. Unfortunately, this antibody is no longer available. We tested recently a commercial anti-Rad52 antibody (Santa Cruz), but we found that it cross-reacts with Rad51. We also used an anti-FLAG antibody because Rad52 is FLAG-tagged in our experiments. This antibody revealed Rad52-FLAG in cell extracts analyzed by western blotting and was used in our co-IP and ChIP experiments. However, this antibody cannot detect Rad52 associated with Rad51 filaments in gel shift assays. The tag might be hidden in the context of the Rad52/Rad51/ssDNA complex, or Rad52 C-terminus could suffer proteolysis in vitro. Altogether, these results are disappointing, but we think that our EM study of Rad51 filament formation on PhiX174 DNA shows the effect of *rad52-Y376A* and *rad52P381S* on the association of Rad52 with Rad51 filaments (now Figure 5B). We also used this gel shift assay to try to confirm the Rad52 inhibitory effect on Srs2 activity observed by EM (now Figure 5D). However, we failed. Again, this might be caused by the low number of Rad52 molecules associated with filaments assembled on 400nt-long ssDNA. Therefore, there might be a minimum size of Rad51 filament required to observe the effect of Rad52 on Srs2. We cannot exclude either that the PhiX174 DNA circular nature is important for observing this inhibition in vitro. These hypotheses will require to be tested in a complete study of the inhibition of Srs2 by Rad52. We decided not to include these results in the manuscript at this time.

> \- Although Rad52 does not inhibit ATPase activity of Srs2, it is important to show that Rad52 by itself does not inhibit the helicase activity of Srs2, given that Rad52 to Srs2 interacts with each other.

We faced a technical problem also with this experiment (see annex) and decided not to include it in our manuscript.

> \- The ChIP-qPCR shown in Figure 5 for Rad52 seems to have been performed with a Rad52-FLAG. Since the authors are analyzing two specific mutants for Rad52, it seems that they are detecting is a WT copy of Rad52 carrying FLAG, so that the mutant rad52 proteins are not detected. Those experiments need to be explained better how they were performed. If the authors are detecting only wt Rad52, this needs to be discussed. It is unclear what would be meaning of those data because authors are not detecting the mutant Rad52, subject of study. The results as such are confusing and needs to be clarified.

These experiments were done in haploid cells. Therefore, there is only one of Rad52-FLAG that is expressed (WT or mutant). The protein detected is WT or mutant and there is never co-expression of WT and mutant protein. This has been clarified in the text (subsection "Rad52 interaction with Rad51 is dispensable for Rad51 filament formation at a HO-induced DSB but is essential for preventing Rad51 filament disassembly by Srs2").

> \- It is a bit surprising to use a SSA system that does not allow for identification of recombinants by a genetic selection of Leu2+ recombinants. However, authors should try to determine recombination via qPCR in the SSA assay used in Figure 4. It would be nice to see whether in the srs2 rad52-P381S and srs2 rad52-Y376S mutants the frequency of recombination accompanies the data of survival.

A system that allows the formation of LEU^+^ recombinants would allow the formation of prototrophes by gene conversion. The SSA system we used was designed by (Vaze et al., 2002) to allow the repair of a HO-induced DSB only by SSA and not by a classical gene conversion mechanism (DSBR). This is why repair events cannot be selected. As described in the 2002 paper, the amount of product in Srs2-deficient cells does not reflect cell survival. The amount of product is surprisingly high despite the low viability of Srs2-deficient cells. We repeated this experiment by using PCR with primers that specifically amplify the repair products and showed that the amount of product was roughly the same in WT and *srs2*∆ cells. We also found the same for *rad52-Y376A* and *rad52-Y376A srs2*∆ cells. Because this was described earlier for *srs2*∆, and was not changed by *rad52-Y376A*, we chose not to add it in the paper.

**Annex**

Pull-down assay

When trying to set up the pull-down assay, we faced several problems that are, in part, related to the complexity of Rad51 filament formation in vitro. As described by Esta et al. (2013), the addition of Rad51 and Rad52 to a 400nt-long ssDNA resulted mostly in partial Rad51 filament formation, and only 4% of the ssDNA molecules were completely covered by Rad51, as indicated by the EM results. RPA is essential to form complete Rad51 filaments. Additionally, the stoichiometry of RPA, Rad51, Rad52 and ssDNA has to be very precise to allow complete Rad51 filament formation. Increasing Rad52 concentration results in an inhibition of Rad51 filament formation, which makes difficult to test the effect of Rad52 on Rad51 filament stability or on Srs2 activity. We also observed previously by EM (Esta et al., 2013) that only 10% of complete Rad51 filaments formed on a 400nt-long ssDNA is associated with more than one Rad52 spot. This might decrease the chance to observe an effect of Rad52 on Rad51 filaments assembled on small molecules.

Therefore, first, we tried to assemble complete Rad51 filaments on a 60mer biotinylated oligonucleotide. The major problem we encountered was the high unspecific association of Rad51 with the streptavidin-coated magnetic beads (Invitrogen). By trying different conditions, we could at best reduce Rad51 unspecific binding to 20%; however, in these conditions of salt concentration and temperature, Rad52 mediator activity could not be observed (i.e., there was as much Rad51 retained on beads coated with RPA-covered ssDNA in the presence or in the absence of Rad52). Additionally, because the affinity of Rad52 for naked DNA is high, it is impossible to distinguish DNA-bound Rad52 from Rad51 filament-bound Rad52 with this technique.

Then, to reduce the signal/background ratio, we used a 400nt-long ssDNA that shares homology with the biotinylated oligonucleotide to bind it to the streptavidin beads. Unfortunately, we observed high unspecific binding of the 400nt-long ssDNA to the beads in the absence of the oligonucleotide. We varied the salt concentration in the buffer used to coat the beads with the 60mer oligonucleotide. Yet, at best we still found 30% of unspecific binding of the 400nt-long ssDNA to the beads. We considered that we could not proceed on Rad51 filament formation with such a high background.

Srs2 helicase activity assay

We used a 200bp dsDNA substrate with a 400nt-long 3' overhang, resulting from the pairing of a 600nt ssDNA with a complementary 200nt ssDNA. Srs2 must be loaded on ssDNA to be able to unwind dsDNA. It cannot unwind a blunted end dsDNA. Srs2 displays a poor helicase activity on this substrate. As described previously by several laboratories (REF?), Srs2 helicase activity is strongly enhanced by Rad51 pre-coated on ssDNA. To test the effect of Rad52 on Srs2 helicase activity, we formed Rad51 filaments by adding Rad52 and Rad51 on the substrate pre-coated with saturating amount of RPA. We found that Rad52 does not reduce Srs2 helicase activity. However, our controls show that saturating amount of RPA on the 3' tail stimulates Srs2 helicase activity as efficiently as Rad51, thus preventing us to reach a valid conclusion.
